GlassScriptPhysician profile
Johnnie L Alston
NPI 1518128669
$9,460.36
in general payments reported to CMS, 2019-2025
28 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,713 · 2020: $3,497 · 2021: $524 · 2022: $454 · 2023: $344 · 2024: $393 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,233 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.84 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $6,468.19 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $489.26 | 2019-2025 | Nuzyra |
| Smith+Nephew, INC. | $225.49 | 2019-2025 | Collagenase Santyl |
| Abbvie INC. | $208.70 | 2021-2023 | Teflaro |
| Melinta Therapeutics, LLC | $203.61 | 2019-2022 | |
| Organogenesis INC. | $175.67 | 2019-2021 | |
| Stryker Corporation | $167.33 | 2021-2025 | Dart-Fire, Fuseforce, Easyfuse |
| Vaporox, INC. | $167.00 | 2023 | Vht-200 Wound Treatment System |
| Horizon Therapeutics Plc | $164.34 | 2019-2023 | Krystexxa |
| Cumberland Pharmaceuticals, INC. | $157.60 | 2019-2022 | |
| Allergan, INC. | $114.36 | 2019-2021 | |
| Solventum Corporation | $111.92 | 2024-2025 | Activ.A.C. |
| Celularity INC. | $107.00 | 2019 | |
| Ossur Americas, INC. | $106.36 | 2025 | |
| Boston Scientific Corporation | $101.97 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $97.55 | 2025 | Purified Cortrophin Gel |
| Kci USA, INC. | $73.09 | 2020-2023 | Activ.A.C. Ion Progress, Activ.A.C. |
| Amgen INC. | $59.68 | 2024 | Krystexxa |
| Convatec INC. | $55.19 | 2019-2021 | |
| Kerecis Limited | $40.93 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $40.60 | 2025 | |
| Integra Lifesciences Corporation | $29.68 | 2019 | |
| Bioventus LLC | $20.64 | 2025 | Exogen Ultrasound Bone Healing System |
| Cardiovascular Systems INC. | $18.06 | 2021 | |
| 3m Company | $16.11 | 2019 | |
| Acera Surgical, INC. | $15.34 | 2021 | |
| Averitas Pharma INC. | $13.62 | 2024 | Qutenza |
| Wright Medical Technology, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnnie Alston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.